Idiopathic Hypereosinophilic Syndrome in Children-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Idiopathic Hypereosinophilic Syndrome in Children

Published:2005-12 Issue:12 Volume:27 Page:663-665
ISSN:1077-4114
Container-title:Journal of Pediatric Hematology/Oncology
language:en
Short-container-title:

Author:

Rives Susana,Alcorta Iñaki,Toll Teresa,Tuset Esperanza,Estella Jesús,Cross Nicholas C. P

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Reference14 articles.

1. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome.;Cools;N Engl J Med,2003

2. Pediatric hypereosinophilic syndrome (HES) differs from adult HES.;Katz;J Pediatr,2005

3. Abnormal clones of interleukin-5-producing T cells in idiopathic eosinophilia.;Simon;N Engl J Med,1999

4. Molecular characterization of the idiopathic hypereosinophilic syndrome (HES) in 35 French patients with normal conventional cytogenetics.;Roche-Lestienne;Leukemia,2005

5. The idiopathic hypereosinophilic syndrome.;Alfaham;Arch Dis Child,1987

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management;American Journal of Hematology;2024-03-29

2. Mastocytosis and Myeloid Lymphoid Neoplasms with Eosinophilia;Atlas of Pediatric Hematopathology;2023-07-13

3. Case Report: Pediatric myeloid/lymphoid neoplasm with eosinophilia and PDGFRA rearrangement: The first case presenting as B-lymphoblastic lymphoma;Frontiers in Pediatrics;2022-12-14

4. World Health Organization‐defined eosinophilic disorders: 2022 update on diagnosis, risk stratification, and management;American Journal of Hematology;2021-10-08

5. Sustained Complete Molecular Remission With Imatinib Monotherapy in a Child Presenting With Blast Phase FIP1L1-PDGFRA-Associated Myeloid Neoplasm With Eosinophilia;HemaSphere;2020-11-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3